In a study using the 5XFAD mouse model of AD, TREM2 was activated by a TREM2 agonistic antibody tetra-variable domain immuno-globulin (Ab18 TVD-Ig), which increased TREM2 activation by 100-fold compared to its bivalent form. This evidence concerns the gene TREM2 and Alzheimer disease.